Search

Cathy A. Maccormac

Examiner (ID: 10138, Phone: (571)272-2652 , Office: P/2918 )

Most Active Art Unit
2914
Art Unit(s)
2904, 2916, 2918, 2903, 2914
Total Applications
5457
Issued Applications
5319
Pending Applications
0
Abandoned Applications
138

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6024301 [patent_doc_number] => 20110052627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'RECOMBINANT MODIFIED VACCINIA VIRUS MEASLES VACCINE' [patent_app_type] => utility [patent_app_number] => 12/937412 [patent_app_country] => US [patent_app_date] => 2009-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21307 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052627.pdf [firstpage_image] =>[orig_patent_app_number] => 12937412 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/937412
RECOMBINANT MODIFIED VACCINIA VIRUS MEASLES VACCINE Jun 7, 2009 Abandoned
Array ( [id] => 4598622 [patent_doc_number] => 07976850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Pox viridae treatment' [patent_app_type] => utility [patent_app_number] => 12/474331 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6272 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/976/07976850.pdf [firstpage_image] =>[orig_patent_app_number] => 12474331 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/474331
Pox viridae treatment May 28, 2009 Issued
Array ( [id] => 8469627 [patent_doc_number] => 08298805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Signal for packaging of influenza virus vectors' [patent_app_type] => utility [patent_app_number] => 12/470287 [patent_app_country] => US [patent_app_date] => 2009-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 42 [patent_no_of_words] => 24328 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 250 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12470287 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/470287
Signal for packaging of influenza virus vectors May 20, 2009 Issued
Array ( [id] => 5490357 [patent_doc_number] => 20090291428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF POXVIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/469535 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 15957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291428.pdf [firstpage_image] =>[orig_patent_app_number] => 12469535 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/469535
COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF POXVIRAL INFECTIONS May 19, 2009 Abandoned
Array ( [id] => 6340234 [patent_doc_number] => 20100247572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'VIRUSES ENCODING MUTANT MEMBRANE PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/467492 [patent_app_country] => US [patent_app_date] => 2009-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15738 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247572.pdf [firstpage_image] =>[orig_patent_app_number] => 12467492 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/467492
VIRUSES ENCODING MUTANT MEMBRANE PROTEIN May 17, 2009 Abandoned
Array ( [id] => 5551776 [patent_doc_number] => 20090285762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'IMAGING METHODS AND COMPOSITIONS COMPRISING FLUORESCENT DYES ASSOCIATED WITH VIRAL COMPONENTS FOR NERVE IMAGING' [patent_app_type] => utility [patent_app_number] => 12/466122 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9441 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285762.pdf [firstpage_image] =>[orig_patent_app_number] => 12466122 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/466122
Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging May 13, 2009 Issued
Array ( [id] => 5984826 [patent_doc_number] => 20110097417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'MELAN-A-CARRIER CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/463985 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 47822 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097417.pdf [firstpage_image] =>[orig_patent_app_number] => 12463985 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/463985
MELAN-A-CARRIER CONJUGATES May 10, 2009 Abandoned
Array ( [id] => 4624019 [patent_doc_number] => 08003314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-23 [patent_title] => 'Methods for direct fluorescent antibody virus detection in liquids' [patent_app_type] => utility [patent_app_number] => 12/425256 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30310 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/003/08003314.pdf [firstpage_image] =>[orig_patent_app_number] => 12425256 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/425256
Methods for direct fluorescent antibody virus detection in liquids Apr 15, 2009 Issued
Array ( [id] => 6038451 [patent_doc_number] => 20110091500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Inactivated Live-Attenuated Bluetongue Virus Vaccine' [patent_app_type] => utility [patent_app_number] => 12/988282 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6132 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091500.pdf [firstpage_image] =>[orig_patent_app_number] => 12988282 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/988282
Inactivated Live-Attenuated Bluetongue Virus Vaccine Apr 15, 2009 Abandoned
Array ( [id] => 5457859 [patent_doc_number] => 20090258011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Antibodies against west nile virus and therapeutic and prophylactic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/385346 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 49499 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258011.pdf [firstpage_image] =>[orig_patent_app_number] => 12385346 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/385346
Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof Apr 5, 2009 Issued
Array ( [id] => 8027881 [patent_doc_number] => 08143020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Enhanced metabolite generation' [patent_app_type] => utility [patent_app_number] => 12/417881 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5222 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143020.pdf [firstpage_image] =>[orig_patent_app_number] => 12417881 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/417881
Enhanced metabolite generation Apr 2, 2009 Issued
Array ( [id] => 6479557 [patent_doc_number] => 20100041740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'FLU VACCINES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/417556 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 20439 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041740.pdf [firstpage_image] =>[orig_patent_app_number] => 12417556 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/417556
Flu vaccines and methods of use thereof Apr 1, 2009 Issued
Array ( [id] => 5385241 [patent_doc_number] => 20090226486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'N protein mutants of porcine reproductive and respiratory syndrome virus' [patent_app_type] => utility [patent_app_number] => 12/383937 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11464 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226486.pdf [firstpage_image] =>[orig_patent_app_number] => 12383937 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/383937
N protein mutants of porcine reproductive and respiratory syndrome virus Mar 29, 2009 Issued
Array ( [id] => 6349444 [patent_doc_number] => 20100249043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH' [patent_app_type] => utility [patent_app_number] => 12/413436 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3043 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249043.pdf [firstpage_image] =>[orig_patent_app_number] => 12413436 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/413436
COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH Mar 26, 2009 Abandoned
Array ( [id] => 6202309 [patent_doc_number] => 20110065095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'ANTI-(INFLUENZA A VIRUS SUBTYPE H5 HEMAGGLUTININ) MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/934908 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12529 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065095.pdf [firstpage_image] =>[orig_patent_app_number] => 12934908 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/934908
Anti-(influenza a virus subtype H5 hemagglutinin) monoclonal antibody Mar 25, 2009 Issued
Array ( [id] => 6353429 [patent_doc_number] => 20100086564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'West Nile Virus Vaccine' [patent_app_type] => utility [patent_app_number] => 12/409120 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5765 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086564.pdf [firstpage_image] =>[orig_patent_app_number] => 12409120 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/409120
West nile virus vaccine Mar 22, 2009 Issued
Array ( [id] => 6228909 [patent_doc_number] => 20100183647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor' [patent_app_type] => utility [patent_app_number] => 12/382425 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 34955 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183647.pdf [firstpage_image] =>[orig_patent_app_number] => 12382425 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/382425
Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor Mar 15, 2009 Abandoned
Array ( [id] => 6202307 [patent_doc_number] => 20110065093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'NOVEL TOOL FOR THE ANALYSIS OF NEURAL CIRCUITS' [patent_app_type] => utility [patent_app_number] => 12/921865 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7279 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065093.pdf [firstpage_image] =>[orig_patent_app_number] => 12921865 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/921865
NOVEL TOOL FOR THE ANALYSIS OF NEURAL CIRCUITS Mar 8, 2009 Abandoned
Array ( [id] => 7987219 [patent_doc_number] => 08075903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-13 [patent_title] => 'Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4' [patent_app_type] => utility [patent_app_number] => 12/398043 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 30973 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/075/08075903.pdf [firstpage_image] =>[orig_patent_app_number] => 12398043 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/398043
Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 Mar 3, 2009 Issued
Array ( [id] => 5533106 [patent_doc_number] => 20090232894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Process for Stabilizing an Adjuvant Containing Vaccine Composition' [patent_app_type] => utility [patent_app_number] => 12/397140 [patent_app_country] => US [patent_app_date] => 2009-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11089 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232894.pdf [firstpage_image] =>[orig_patent_app_number] => 12397140 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/397140
Process for stabilizing an adjuvant containing vaccine composition Mar 2, 2009 Issued
Menu